UC-Berkeley researchers created affordable anti-malaria drug artemisinin
On Apr. 12, 2006, chemical engineer Jay Keasling helped create an affordable anti-malaria drug, artemensins, by producing arteminsic…
On Apr. 12, 2006, chemical engineer Jay Keasling helped create an affordable anti-malaria drug, artemensins, by producing arteminsic…
On Mar. 27, 2006, The Priestley Medal was awarded to Paul S. Anderson by the American Chemical Society…
On Mar. 8, 2006, World Kidney Day, a joint initiative between the International Society of Nephrology (ISN) and…
On Feb. 24, 2006, the Advisory Committee on Immunization Practices (ACIP) was informed by the only U.S.-licensed manufacturer…
On Oct. 17, 2005, the FDA approved lowering the age limit to 12 mos for the remaining U.S.-licensed…
On Oct. 11, 2005, the National Cancer Institute announced the Transdisciplinary Research on Energetics and Cancer (TREC) initiative…
On Oct. 7, 2005, Jeffery Taubenberger, AH Reid, AE Krafft, Karen Bijwaard and Thomas Fanning published a report…
On Sept. 28, 2005, the National Cancer Institute and the National Institute of Neurological Disorders and Stroke (NINDS)…
On Sept. 26, 2005, San Diego business leader and philanthropist John J. Moores contributed $4 million to The…
On Aug. 31, 2005, the inactivated, injectable influenza vaccine (Fluarix by GlaxoSmithKline) was licensed. The vaccine was indicated…
On Aug. 18, 2005, the Medically Fragile Children’s Program was established at the Medical University of South Carolina….
On May 6, 2005, the National Cancer Institute announced the Community Networks Program (CNP), a 5-year initiative to…
On May 3, 2005, the cellular pertussis vaccine combined with the adult formulation of tetanus and diphtheria (Tdap:…
On Apr. 29, 2005, Amylin Pharmaceuticals and Eli Lilly announced the FDA had approved BYETTA(TM) (exenatide) injection as…
On Mar. 15, 2005, University of California, Los Angeles (UCLA) officials announced the formation of the Institute for…
On Mar. 7, 2005, the CDC commissioned the Nebraska Biocontainment Unit at UNMC. The funding came from federal…
On Feb. 16, 2005, in preparation for the new generation of molecular-based oncology medical products, the National Cancer…
On Feb. 16, 2005, Formation of the Drug Safety Board was announced, consisting of FDA staff and representatives…
On Jan. 8, 2005, researchers from Baylor University Medical Center reported that although the origin of smallpox is…
In Jan. 2005, the Institute for Translational Medicine and Therapeutics (ITMAT) was established at Penn’s Perelman School of…
In 2005, The Patient Navigator Research Program (PNRP), a National Cancer Institute initiative, was underway to assess the…
In 2005 and 2006, the White House Homeland Security Council outlined the National Strategy for Pandemic Influenza to…
In 2005, Robert H. Grubbs, a professor at Caltech, shared the Nobel Prize for Chemistry with Yves Chauvin…
On Dec. 15, 2004, Amgen announced that following priority review, the FDA has approved Kepivance(TM) (palifermin), the first…
On Nov. 18, 2004, scientists at the National Cancer Institute created a model that predicts the survival of…
On Oct. 4, 2004, the Nobel Assembly announced the award of the Nobel Prize in Physiology or Medicine…
In Oct. of 2004, the Hotchkiss Brain Institute was launched under the leadership of Dr. Samuel Weiss with…
On Aug. 25, 2004, a significant shortage of influenza vaccine occurred in the U.S. as a result of…
On Jun. 3, 2004, the National Cancer Institute’s Annual Report to the Nation found cancer incidence and death…
On May 7, 2004, the Health Sciences Learning Center opened near the University of Wisconsin Hospital and Clinics….